BONESUPPORT launches next generation of CERAMENT® G

BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announces the launch of the next generation of the company’s breakthrough antibiotic-eluting bone graft substitute, CERAMENT G. Improvements to CERAMENT G have been made to increase ease of use and to reduce environmental impact.

The same composition, mechanism of action, and clinical results as previous versions of CERAMENT G apply, but all components in the kit are now surface sterile. In addition, the shelf life of the product has been extended by one year, to a total of three years. The improvements create a better workflow during surgery leading to increased ease of use and user efficiency. Furthermore, the physical dimensions of the new CERAMENT G kit are 28% smaller than before with packaging material reduced by 35%. The kit improvements were made after extensive consultation with customers.

“Surgical teams value that CERAMENT G comes in an all-in-one kit and this latest update offers greater efficiency in the operating room. At same time, the product’s reduced packaging waste is a step forward in our corporate sustainability objectives,” said Emil Billbäck, CEO of BONESUPPORT.

The next generation of CERAMENT G is first released in Europe and then in other markets over the coming months.